HNN3.0
Register
Register
Register

Project cooperationUpdated on 10 January 2026

ForecomAI: Enhanced Image Analysis for Next-Generation NAM Platforms

CEO at ForecomAI

London, United Kingdom

About

We offer AI and multimodal computational capabilities suited to the development, optimisation, and validation of NAM platforms under HORIZON-HLTH-2026-01-TOOL-03. Our expertise includes: (i) quantitative cell morphology modelling from fluorescence and brightfield imaging; (ii) protein subcellular localisation; and (iii) multimodal architectures integrating imaging with gene, protein, and compound information to support mechanism-of-action inference, quality control, and predictive performance. We are seeking partners forming consortia to build scalable, human-relevant NAMs using iPSC-derived systems, organoids, or organ-on-chip models, particularly where high-content imaging and rigorous image analysis are necessary to improve disease-modelling precision, support regulatory-aligned validation strategies, and enhance confidence in AI-enabled predictions.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Organisation

ForecomAI

Company (SME)

London, United Kingdom

Similar opportunities

  • Project cooperation

    Translational NAMs in pharmacology & toxicology for drug profiling

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Nikolas Dietis

    Assistant Professor of Pharmacology at University of Cyprus

    Nicosia, Cyprus

  • Project cooperation

    Salivary Liquid Biopsy as a Human-Relevant NAM for Regulatory and Biomedical Research

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Victoria Barygina

    progect manager at NSight Dynamics s.r.l.

    Florence, Italy

  • Project cooperation

    Advancing Single-Molecule De-Novo Protein Sequencing

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Til Schlotter

    ETH Researcher, Co-founder & CEO at UNOMR AG

    Zurich, Switzerland